Foulon; Loic

Patent Applications and Registrations

Patent applications and USPTO patent grants for Foulon; Loic.The latest application filed is for "1,3-dihydro-2h-pyrrolo[3,2-b]pyridin-2-one derivatives, preparation thereof and therapeutic uses thereof".

Company Profile

0.12.6

Foulon; Loic - Paris N/A FR
FOULON; Loic - Villeneuve-Toscane FR
FOULON; Loic - Port Sur Garonne FR
FOULON; Loic - Portet Sur Garonne FR
Foulon; Loic - Garonne FR
Foulon; Loic - Pinsaguel FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
3-aminoalkyl-1,3-dihydro-2H-indol-2-one derivatives, preparation thereof and therapeutic use thereof Grant 8,362,067 - Foulon , et al. January 29, 2	2013-01-29
1,3-dihydro-2H-pyrrolo[3,2-bpyridin-2-one derivatives, preparation thereof and therapeutic uses thereof Grant 8,324,214 - Couturier , et al. December 4, 2	2012-12-04
1,3-DIHYDRO-2H-PYRROLO[3,2-b]PYRIDIN-2-ONE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USES THEREOF App 20110071160 - COUTURIER; Cedric ; et al.	2011-03-24
Novel 3-aminoalkyl-1,3-dihydro-2h-indol-2-one Derivatives, Preparation Thereof And Therapeutic Use Thereof App 20110059955 - FOULON; Loic ; et al.	2011-03-10
5-alkyloxy-indolin-2-one Derivatives, Preparation Thereof And Application Thereof In Therapy App 20100069384 - FOULON; Loic ; et al.	2010-03-18
Indolin-2-one pyridine derivatives, preparation and therapeutic use thereof Grant 7,488,743 - Foulon , et al. February 10, 2	2009-02-10
Novel Indolin-2-one Derivatives, Their Preparation and the Pharmaceutical Compositions Comprising Them App 20070203184 - FOULON; Loic ; et al.	2007-08-30
Indolin-2-one Pyridine Derivatives, Preparation And Therapeutic Use Thereof App 20070185166 - Foulon; Loic ; et al.	2007-08-09
Novel indolin-2-one derivatives, their preparation and the pharmaceutical compositions comprising them App 20040059132 - Foulon, Loic ; et al.	2004-03-25
Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands Grant 6,673,790 - Foulon , et al. January 6, 2	2004-01-06
Indolin-2-one derivatives, method for preparing them and pharmaceutical compositions containing them Grant 6,090,818 - Foulon , et al. July 18, 2	2000-07-18
3-spiro-indolin-2-one derivatives as vasopressin and/or oxytocin receptor ligands Grant 5,994,350 - Foulon , et al. November 30, 1	1999-11-30
1-benzenesulfonyl-1-1,3-dihydroindol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present Grant 5,849,780 - Di Malta , et al. December 15, 1	1998-12-15
1-benzenesulfonyl-1,3-dihydroindol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present Grant 5,726,322 - Di Malta , et al. March 10, 1	1998-03-10
1-benzyl-1,3-dihydroindol-2-one derivatives, their preparation and the pharmaceutical compositions in which they are present Grant 5,696,145 - Foulon , et al. December 9, 1	1997-12-09
Compounds bearing sulphamoyl and amidino radicals, their preparation process and pharmaceutical compositions containing them Grant 5,674,890 - Christophe , et al. October 7, 1	1997-10-07
1-benzenesulfonyl-1,3-dihydro-indol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present Grant 5,663,431 - Di Malta , et al. September 2, 1	1997-09-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.